 | Up a level |
2014
Maus, M. K. H., Grimminger, P. P., Mack, P. C., Astrow, S. H., Stephens, C., Zeger, G., Hsiang, J., Brabender, J., Friedrich, M., Alakus, H., Hoelscher, A. H., Lara, P., Danenberg, K. D., Lenz, H. J. and Gandara, D. R. (2014). KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies. Lung Cancer, 83 (2). S. 163 - 168. CLARE: ELSEVIER IRELAND LTD. ISSN 1872-8332
Ramalingam, S. S., Mazieres, J., Planchard, D., Stinchcombe, T. E., Dy, G. K., Antonia, S. J., Horn, L., Lena, H., Minenza, E., Mennecier, B., Otterson, G. A., Campos, L. T., Gandara, D. R., Levy, B. P., Nair, S. G., Zalcman, G., Wolf, J., Baudelet, C., Lestini, B. J. and Rizvi, N. A. (2014). Phase II Study of Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in Patients with Advanced, Refractory Squamous Non-Small Cell Lung Cancer. Int. J. Radiat. Oncol. Biol. Phys., 90 (5). S. 1266 - 1268. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-355X